Raymond James & Associates’s Tonix Pharmaceuticals TNXP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14	Closed	-$70.1K	–	3870
2023 Q2	$70.1K	Buy	14 +1	+8%	+$5.01K	﹤0.01%	3627
2023 Q1	$157K	Buy	13 +5	+63%	+$60.5K	﹤0.01%	3512
2022 Q4	$65.5K	Buy	+8	New	+$65.5K	﹤0.01%	3645